ClinChoice Overview
- Year Founded
-
1995
- Status
-
Private
- Employees
-
1,625
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$150M
- Investors
-
16
ClinChoice General Information
Description
Provider of clinical research and product development services intended to accelerate the development and commercialization of healthcare products. The company offers clinical development, biometrics, regulatory affairs, safety monitoring, medical writing, data science, and quality management services, enabling pharmaceutical, biotechnology, medical device, diagnostic, and consumer health organizations to advance products through development and regulatory approval with compliance and operational efficiency.
Contact Information
Website
www.clinchoice.comCorporate Office
- 300 Welsh Road, Building 5
- Suite 201
- Horsham, PA 19044
- United States
Corporate Office
- 300 Welsh Road, Building 5
- Suite 201
- Horsham, PA 19044
- United States
ClinChoice Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series E) | 04-Jul-2022 | $150M | Completed | Generating Revenue | ||
| 6. Secondary Transaction - Private | 08-Nov-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 25-Oct-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Jan-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2009 | $1.72M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-Nov-2007 | $1.72M | $1.72M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ClinChoice Comparisons
Industry
Financing
Details
ClinChoice Competitors (28)
One of ClinChoice’s 28 competitors is KCR, a Formerly PE-Backed company based in Warsaw, Poland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| KCR | Formerly PE-Backed | Warsaw, Poland | ||||
| Atlant Clinical | Corporate Backed or Acquired | Moscow, Russia | ||||
| Rho | Corporation | Durham, NC | ||||
| Parexel International | Private Equity-Backed | Raleigh, NC | ||||
| Taconic Biosciences | Private Equity-Backed | Rensselaer, NY |
ClinChoice Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ClinChoice Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ClinChoice Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Draper Associates | Venture Capital | Minority | ||
| Draper Dragon | Venture Capital | Minority | ||
| Goldman Sachs Growth Equity | Growth/Expansion | Minority | ||
| Legend Capital | Venture Capital | Minority | ||
| Rencent Capital | Venture Capital | Minority |
ClinChoice Investments & Acquisitions (5)
ClinChoice’s most recent deal was a Merger/Acquisition with CSI Medical Research. The deal was made on 11-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CSI Medical Research | 11-Jan-2024 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| ImmuneOnco | 05-Sep-2023 | IPO | Drug Discovery | ||
| Cromsource | 28-Feb-2023 | Merger/Acquisition | Practice Management (Healthcare) | ||
| Laibiyi Technology | 13-Jan-2022 | Merger/Acquisition | Practice Management (Healthcare) | ||
| FMD K&L | 30-Jul-2014 | Merger/Acquisition | Practice Management (Healthcare) |
ClinChoice Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CSI Medical Research | Singapore, Singapore | 2017 | |
| Laibiyi Technology | Xiamen, China | 2016 |
ClinChoice FAQs
-
When was ClinChoice founded?
ClinChoice was founded in 1995.
-
Where is ClinChoice headquartered?
ClinChoice is headquartered in Horsham, PA.
-
What is the size of ClinChoice?
ClinChoice has 1,625 total employees.
-
What industry is ClinChoice in?
ClinChoice’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is ClinChoice a private or public company?
ClinChoice is a Private company.
-
What is the current valuation of ClinChoice?
The current valuation of ClinChoice is .
-
What is ClinChoice’s current revenue?
The current revenue for ClinChoice is .
-
How much funding has ClinChoice raised over time?
ClinChoice has raised $214M.
-
Who are ClinChoice’s investors?
Draper Associates, Draper Dragon, Goldman Sachs Growth Equity, Legend Capital, and Rencent Capital are 5 of 16 investors who have invested in ClinChoice.
-
Who are ClinChoice’s competitors?
KCR, Atlant Clinical, Rho, Parexel International, and Taconic Biosciences are some of the 28 competitors of ClinChoice.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
